Pulike Biological Engineering

Pulike Biological Engineering PEG

The PEG Ratio (Price/Earnings-to-Growth) of Pulike Biological Engineering (603566.SS) as of Oct 17, 2026 is 7.68. In the previous year, PEG Ratio (Price/Earnings-to-Growth) was 15.30 — a change of -49.83% (lower).

PEG

7.68

YoY

-49.83%

Last updated:

PEG Ratio (Price/Earnings-to-Growth) of Pulike Biological Engineering is 2025 7.68 . PEG Ratio (Price/Earnings-to-Growth) of Pulike Biological Engineering was 2024 15.30 . It decreases by -49.83% lower compared to the previous year.

The Pulike Biological Engineering PEG history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

PEG
Date
PEG
Jan 1, 2018
10.47 CNY
Jan 1, 2019
13.00 CNY
Jan 1, 2020
6.55 CNY
Jan 1, 2021
5.82 CNY
Jan 1, 2022
8.46 CNY
Jan 1, 2023
8.14 CNY
Jan 1, 2024
15.30 CNY
Jan 1, 2025
7.68 CNY
The Pulike Biological Engineering PEG history
YEARPEGYoY
7.68-49.83%
15.30+88.04%
8.14-3.84%
8.46+45.48%
5.82-11.25%
6.55-49.58%
13.00+24.14%
10.47-15.80%
12.44+64.65%
7.55-24.61%
10.02-1.05%
10.13—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Pulike Biological Engineering Stock analysis

What does Pulike Biological Engineering do? Pulike Biological Engineering Inc, listed on the Shanghai Stock Exchange with ticker 603566.SS and ISIN CNE1000025N0, is a pharmaceutical company based in Luoyang, China. The company went public on May 18, 2015. It employs 1,718 people and operates within the healthcare sector, specifically in the pharmaceuticals industry. Pulike Biological Engineering focuses on the research, development, manufacturing, and sale of biological products for animals, chemical drugs, and Chinese veterinary drugs. The company's veterinary biological products include vaccines and antibodies, which are used for the prevention and control of infectious diseases in poultry and livestock. Its veterinary chemical medicines are primarily used for treating epidemic diseases affecting poultry and livestock. The company is headquartered in Luoyang, Henan, and its website is http://www.pulike.com.cn/. Pulike Biological Engineering Inc is engaged in the research, development, production, and distribution of veterinary biological products and chemical medicines. The firm's product portfolio targets the prevention and treatment of diseases in animals, with a focus on poultry and livestock health management. Pulike Biological Engineering is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Pulike Biological Engineering stock

PEG Ratio (Price/Earnings-to-Growth) of Pulike Biological Engineering is 7.68 in 2025.

PEG Ratio (Price/Earnings-to-Growth) of Pulike Biological Engineering changed from 15.30 to 7.68, representing a -49.83% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of PEG Ratio (Price/Earnings-to-Growth) Pulike Biological Engineering since 2006 – with annual values, charts, and detailed analysis.

The PEG ratio adjusts the P/E ratio by the expected earnings growth rate. A PEG below 1 may indicate an undervalued stock relative to its growth potential.

PEG = P/E Ratio / Expected Annual EPS Growth Rate

To evaluate PEG Ratio (Price/Earnings-to-Growth)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for PEG Ratio (Price/Earnings-to-Growth).

A 'good' varies by industry and company stage. On Eulerpool, you can compare PEG Ratio (Price/Earnings-to-Growth)'s Pulike Biological Engineering with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Valuation — Pulike Biological Engineering

P/EP/SEV/EBITP/BP/CFP/FCFPEGEV/RevenueEV/EBITDAEV/FCFEarnings YieldFCF YieldMarket capitalizationEnterprise ValueForward P/EP/TBVShareholder YieldBuyback YieldDiv.-Adj. PEGEV/OCF

All Key Metrics — Pulike Biological Engineering